Find
News Releases
= add release to Briefcase
| All Releases | |||
|---|---|---|---|
 |
Winter Sun's Rays Can Be Damaging to Eyes Nov 27, 2006 |
10.6 KB |
|
|
JACKSONVILLE, Fla., Nov 27, 2006 /PRNewswire via COMTEX News Network/ -- Whether skiing, snowboarding, mountain climbing, shoveling snow, or just strolling outside this winter, it's important to protect your eyes from the sun's powerful ultraviolet (UV) rays. Exposure to UV rays during winter can temporarily harm the eyes as well as increase the ri... |
|||
|
Johnson & Johnson Announces Definitive Agreement to Acquire Conor Medsystems, Inc. Nov 16, 2006 |
14.3 KB |
|
|
NEW BRUNSWICK, N.J. and MENLO PARK, Calif., Nov 16, 2006 /PRNewswire via COMTEX News Network/ -- Conor Medsystems to Complement Cordis' Drug-Eluting Stent Capabilities With Unique Controlled Drug Delivery Technology NEW BRUNSWICK, N.J. and MENLO PARK, Calif., Nov. 16 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) a... |
|||
|
Cordis Corporation To Study Impact Of Contributing Factors To Stent Thrombosis In Expansion Of 30,000-Stent Patient Registry Oct 24, 2006 |
11.9 KB |
|
|
Washington, D.C.(October 24, 2006) – In order to further advance understanding of stent thrombosis, Cordis Corporation announced today a study of the multiple factors that may lead to the condition and potential benefits of medical regimens. The 30,000 patient registry, currently underway in Europe and Asia/Pacific, will now extend to the... |
|||
|
U.S. District Court Grants Request for Preliminary Injunction to Ortho-McNeil Neurologics, Inc. for TOPAMAX(R) Oct 24, 2006 |
6.9 KB |
|
|
TITUSVILLE, N.J., Oct 24, 2006 /PRNewswire via COMTEX News Network/ -- A U.S. District Court has granted the request of Ortho-McNeil Neurologics, Inc., a subsidiary of Johnson & Johnson, for a preliminary injunction against Mylan Laboratories, Inc. prohibiting Mylan from launching a generic version of topiramate (TOPAMAX(R)) prior to a final court ... |
|||
|
Johnson & Johnson Reports 2006 Third-Quarter Results: Sales Increase of 7.9% and EPS of $.94 Versus $.85 a Year Ago; Excluding In-Process Research and Development Charges, EPS Increased 15.3% * Oct 17, 2006 |
19.2 KB |
|
|
NEW BRUNSWICK, N.J., Oct 17, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson today announced sales for the third quarter of $13.3 billion, an increase of 7.9% as compared to the third quarter of 2005. Operational growth was 6.7% with a positive currency impact of 1.2%. Domestic sales were up 7.5%, while international sales ... |
|||
|
Cordis to Host Analyst Meeting at TCT Conference Oct 16, 2006 |
6.7 KB |
|
|
NEW BRUNSWICK, N.J., Oct 16, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Cordis, a Johnson & Johnson company, will host a meeting for financial analysts at 7:30 a.m. (Eastern Daylight Savings Time) on October 24th at the Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, D.C. Investors and other interested part... |
|||
|
U.S. District Court Upholds RISPERDAL(R) Patent Oct 16, 2006 |
7.3 KB |
|
|
TITUSVILLE, N.J., Oct 16, 2006 /PRNewswire via COMTEX News Network/ -- Janssen, L.P. today announced that a U.S. District Court upheld the validity and enforceability of the RISPERDAL(R) (risperidone) patent. The injunction that was entered prohibits Mylan Pharmaceuticals, Inc. and Dr. Reddy's Laboratories, Ltd. from selling their proposed generic ... |
|||
|
Johnson & Johnson to Host Analyst Conference Call on Third-Quarter Results Oct 10, 2006 |
6.5 KB |
|
|
NEW BRUNSWICK, N.J., Oct 10, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson will host a conference call for financial analysts at 8:30 a.m. Eastern Daylight Savings Time on Tuesday, October 17, 2006, to review third-quarter results. Robert J. Darretta, Vice Chairman and Chief Financial Officer, and Louise Mehrotra, Vice Pr... |
|||
|
Robert J. Darretta to Retire as Vice Chairman and CFO of Johnson & Johnson Oct 6, 2006 |
8.4 KB |
|
|
NEW BRUNSWICK, N.J., Oct 06, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson today announced that Robert J. Darretta, Vice Chairman of the Board of Directors and Chief Financial Officer, has elected to retire in early 2007 after a distinguished 38-year career with the Company. "During Bob's tenure over the past decade a... |
|||
|
As U.S. Population Swells to 300 Million, New Survey Examines The Evolution of Motherhood Sep 28, 2006 |
12.1 KB |
|
|
SKILLMAN, N.J., Sept 28, 2006 /PRNewswire via COMTEX News Network/ -- According to demographers from the U.S. Census Bureau, the U.S. population will reach 300 million people this fall. To celebrate this milestone, JOHNSON'S(R) Baby commissioned a survey looking at moms of today and at moms who gave birth in the late 1960s, when the population hit ... |
|||
|
Johnson & Johnson to Participate in Merrill Lynch Conference Sep 13, 2006 |
6.2 KB |
|
|
NEW BRUNSWICK, N.J., Sept 13, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson will participate in The Merrill Lynch Global Pharmaceutical, Biotechnology & MedTech Conference 2006 in London. David Y. Norton, Company Group Chairman, Worldwide Commercial and Operations, will be representing Johnson & Johnson at the conference ... |
|||
|
RNAi Pioneer Craig Mello Named Inaugural Winner of the Dr. Paul Janssen Award for Biomedical Research Sep 12, 2006 |
10.2 KB |
|
|
BEERSE, Belgium, Sept 12, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson today announced that Craig C. Mello, Ph. D., a professor of Molecular Medicine at the University of Massachusetts Medical School, Worcester, MA, and an investigator at the Howard Hughes Medical Institute, has been named the inaugural recipient of The ... |
|||
|
Johnson & Johnson to Participate in the Bear Stearns 19th Annual Health Care Conference Sep 7, 2006 |
6.3 KB |
|
|
NEW BRUNSWICK, N.J., Sept 07, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson will participate in the Bear Stearns 19th Annual Health Care Conference next week at The Grand Hyatt Hotel in New York City. Robert J. Darretta, Vice Chairman and Chief Financial Officer, will be representing Johnson & Johnson at the conference an... |
|||
|
Johnson & Johnson to Host Medical Devices & Diagnostics Business Review Aug 29, 2006 |
7.2 KB |
|
|
NEW BRUNSWICK, N.J., Aug 29, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson will host a Medical Devices and Diagnostics Segment business review for financial analysts beginning at 8:30 am (EDT) on Wednesday, September 6, 2006 at the Hyatt Regency, Jersey City on the Hudson in New Jersey. Michael J. Dormer, Worldwide Ch... |
|||
|
VISTAKON to Introduce New 1-DAY ACUVUE(R) MOIST(TM) Brand Contact Lenses In U.S. - A Breakthrough in Comfort Jul 25, 2006 |
8.9 KB |
|
|
JACKSONVILLE, Fla., July 25, 2006 /PRNewswire via COMTEX News Network/ -- VISTAKON(R), Division of Johnson & Johnson Vision Care, Inc., today announced plans to introduce 1-DAY ACUVUE(R) MOIST(TM) Brand Contact Lenses with breakthrough LACREON(TM) technology in the U.S. Currently the fastest growing daily disposable lens in Japan, 1-DAY ACUVUE MOIS... |
|||
|
Update on FDA Psychopharmacologic Drugs Advisory Committee Meeting for Sept. 7 on Paliperidone Extended-Release Tablets Jul 21, 2006 |
7.5 KB |
|
|
TITUSVILLE, N.J., July 21, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson Pharmaceutical Research and Development, LLC today announced that the Food and Drug Administration's Psychopharmacologic Drugs Advisory Committee's (PDAC) review of the new drug application for paliperidone ER has been canceled. The cancellation came... |
|||
|
Johnson & Johnson Reports 2006 Second-Quarter EPS Increase of 10.5% on Sales Increase of 4.7% Jul 18, 2006 |
18.6 KB |
|
|
NEW BRUNSWICK, N.J., July 18, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson today announced record sales for the second quarter of $13.4 billion, an increase of 4.7% as compared to the second quarter of 2005. Operational growth was 4.8% with a negative currency impact of .1%. Domestic sales were up 4.4%, while internation... |
|||
|
Investigational Drug Paliperidone ER Significantly Delayed Symptom Recurrence In Clinical Study of Patients With Schizophrenia Jul 12, 2006 |
10.6 KB |
|
|
CHICAGO, July 12, 2006 /PRNewswire via COMTEX News Network/ -- Paliperidone extended-release (ER) tablets, an investigational, once-daily oral medication, maintained long-term symptom stability in patients with schizophrenia. Data from a multinational, multicenter phase III study were presented today at the Biennial Congress of the Collegium Intern... |
|||
|
Johnson & Johnson to Host Analyst Meeting to Discuss Second-Quarter Financial Results; Review Pharmaceuticals Business/Pipeline and the Planned Acquisition of Pfizer Consumer Healthcare Jul 12, 2006 |
6.2 KB |
|
|
NEW BRUNSWICK, N.J., July 12, 2006 /PRNewswire via COMTEX News Network/ -- Johnson & Johnson, the world's most broadly based health care products company, will sponsor a meeting for financial analysts at 8:30 a.m. (Eastern Time) on Tuesday, July 18, 2006 to discuss second-quarter financial results as well as review its pharmaceuticals business/pipe... |
|||
|
New Survey Reveals Many Contact Lens Wearers Find Their Lenses Uncomfortable, Disruptive When Experiencing Eye-Allergy Symptoms Jul 11, 2006 |
10.5 KB |
|
|
JACKSONVILLE, Fla., July 11, 2006 /PRNewswire via COMTEX News Network/ -- For many of the nation's 38 million contact lens wearers, allergy season can bring tears, and more, to their eyes. At the peak of an especially-difficult allergy season, a new survey reveals that more than half (54 percent) of contact lens wearers who suffer from eye-related ... |
|||
= add release to Briefcase
